Company: EUDAW
Filing Date: 2025-08-08
Form Type: 424B5
Source: 0001493152-25-011729
Chunk: 17

Company: EUDA Health Holdings Ltd
Filing Date: 2025-08-08
Form: 424B5
Chunk 17
---
 described in this prospectus, as a source of financing.

We intend to use the net proceeds, if any, for general corporate purposes, including possible acquisitions or the expansion of our business and working capital. From time to time, we engage in preliminary discussions and negotiations with various businesses in order to explore the possibility of an acquisition or investment. However, as of the date of this prospectus supplement, we have not entered into any agreements or arrangements which would make any acquisition or investment probable.

Our management will have broad discretion to allocate the net proceeds of this offering. Pending the application of the net proceeds for these purposes, we may invest the net proceeds in short-term, investment-grade securities.

| S-11 |

<div align='center'>DILUTION</div>

The net tangible book value of our ordinary shares as of December 31, 2024,was approximately $(2.91) million, or approximately $(0.08) per share. Net tangible book value per share is equal to the amount of our total tangible assets, less total liabilities, divided by the number of ordinary shares outstanding. Dilution in net tangible book value per share represents the difference between the amount per share paid by purchasers of ordinary shares in this offering and the net tangible book value per share of our ordinary shares immediately afterwards.

After
giving effect to the sale by us of the full principal amount of the Convertible Notes in the amount of $10.0 million at a conversion
price of $2.41 per share, (85% of the last reported sale price of our ordinary shares on August 7, 2025, on Nasdaq) and
after deducting estimated offering expenses, our net tangible book value as of December 31, 2024,
would have been approximately $4.54 million, or $0.11 per share. This represents an immediate increase in net tangible
book value of $0.19 per share to existing stockholders and an immediate dilution of $2.30 per share to new investors purchasing
ordinary shares in this offering.

| Assumed offering price per share                      
 Net tangible book value per share as of December      
 31, 2024                                              |     | (0.08 | ) |     |   | 2.41 |
|:------------------------------------------------------|:----|------:|:--|:----|:--|-----:|
| Increase per share attributable to new investors      
 after giving effect to the offering                   |     |  0.19 |   |